Relationship between Clinical Markers of Glycemia and Glucose Excursion Evaluated by Continuous Glucose Monitoring (CGM).

• SUWA Tomoko

  Metabolism and Endocrinology, Department of Medicine, St. Marianna University School of Medicine, Kanagawa, Japan

• OHTA Akio

  Metabolism and Endocrinology, Department of Medicine, St. Marianna University School of Medicine, Kanagawa, Japan

• MATSUI Tomoya

  Metabolism and Endocrinology, Department of Medicine, St. Marianna University School of Medicine, Kanagawa, Japan

• KOGANEI Rieko

  Metabolism and Endocrinology, Department of Medicine, St. Marianna University School of Medicine, Kanagawa, Japan

• KATO Hiroyuki

  Metabolism and Endocrinology, Department of Medicine, St. Marianna University School of Medicine, Kanagawa, Japan

• KAWATA Takehiro

  Metabolism and Endocrinology, Department of Medicine, St. Marianna University School of Medicine, Kanagawa, Japan

• SADA Yukiyoshi

  Metabolism and Endocrinology, Department of Medicine, St. Marianna University School of Medicine, Kanagawa, Japan

• ISHII Satoshi

  Metabolism and Endocrinology, Department of Medicine, St. Marianna University School of Medicine, Kanagawa, Japan

• KONDO Akihiko

  Metabolism and Endocrinology, Department of Medicine, St. Marianna University School of Medicine, Kanagawa, Japan

• MURAKAMI Kaori

  Metabolism and Endocrinology, Department of Medicine, St. Marianna University School of Medicine, Kanagawa, Japan

• KATABAMI Takuyuki

  Metabolism and Endocrinology, Department of Medicine, St. Marianna University School of Medicine, Kanagawa, Japan

• TANAKA Yasushi

  Metabolism and Endocrinology, Department of Medicine, St. Marianna University School of Medicine, Kanagawa, Japan

抄録

In order to evaluate the relationship between clinical markers of glycemia and glucose excursion, we performed 48-hour continuous glucose monitoring (CGM) in 43 diabetic patients. For the clinical markers, HbA_1c, glycoalbumin (GA), and 1,5-anhydroglucitol (1,5-AG) were measured, and for the parameters of glucose excursion from CGM, average glucose (AG), standard deviation of glucose (SD), the area under the curve for glucose levels >180 mg/dL (AUC_>180), and the difference between the maximum and minimum glucose levels during 48 hours (ΔG_48hr) were analyzed. All patients were treated without any changes of the dosages of oral anti-diabetic agents or insulin for at least the previous 3 months with coefficient of variation (CV) of HbA_1c less than 4 %. In results, while HbA_1c did not show any single correlation with AG, SD, AUC_>180, or ΔG_48hr, both GA and 1,5-AG were significantly related to all these parameters. Furthermore, GA significantly correlated to all CGM parameters, and SD significantly correlated to GA in multiple regression analyses. These results suggest that GA may be a different marker from HbA_1c for diabetic complications, because GA, but not HbA_1c, may reflect not only short-term average glucose but also fluctuation of glucose.

収録刊行物

• Endocrine Journal

  Endocrine Journal 57 (2), 135-140, 2010

  一般社団法人 日本内分泌学会

キーワード

• Glycoalbumin
• Glycated hemoglobin
• 1,5-Anhydroglucitol
• Continuous glucose monitoring

詳細情報

• CRID: 1390282681276592256
• NII論文ID: 10029583647
• NII論文ID: 130004443611
• NII書誌ID: AA10901436
• DOI: 10.1507/endocrj.k09e-234
• COI: 1:STN:280:DC%2BC3c7ktFansg%3D%3D
• ISSN: 13484540
• ISSN: 09188959
• PubMed: 19926921
• Web Site: http://www.jstage.jst.go.jp/article/endocrj/57/2/57_K09E-234/_pdf
• Web Site: https://search.jamas.or.jp/link/ui/2010180665
• 本文言語コード: en
• データソース種別:
  • JaLC
  • Crossref
  • PubMed
  • CiNii Articles
• 抄録ライセンスフラグ: 使用不可